Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Rev Esp Cardiol (Engl Ed) ; 74(3): 216-224, 2021 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-32616434

ABSTRACT

INTRODUCTION AND OBJECTIVES: According to sudden cardiac death guidelines, an implantable cardioverter-defibrillator (ICD) should be considered in patients with LMNA-related dilated cardiomyopathy (DCM) and ≥ 2 risk factors: male sex, left ventricular ejection fraction (LVEF) <45%, nonsustained ventricular tachycardia (NSVT), and nonmissense genetic variants. In this study we aimed to describe the clinical characteristics of carriers of LMNA genetic variants among individuals from a Spanish cardiac-laminopathies cohort (REDLAMINA registry) and to assess previously reported risk criteria. METHODS: The relationship between risk factors and cardiovascular events was evaluated in a cohort of 140 carriers (age ≥ 16 years) of pathogenic LMNA variants (54 probands, 86 relatives). We considered: a) major arrhythmic events (MAE) if there was appropriate ICD discharge or sudden cardiac death; b) heart failure death if there was heart transplant or death due to heart failure. RESULTS: We identified 11 novel and 21 previously reported LMNA-related DCM variants. LVEF <45% (P=.001) and NSVT (P <.001) were related to MAE, but not sex or type of genetic variant. The only factor independently related to heart failure death was LVEF <45% (P <.001). CONCLUSIONS: In the REDLAMINA registry cohort, the only predictors independently associated with MAE were NSVT and LVEF <45%. Therefore, female carriers of missense variants with either NSVT or LVEF <45% should not be considered a low-risk group. It is important to individualize risk stratification in carriers of LMNA missense variants, because not all have the same prognosis.


Subject(s)
Laminopathies , Adolescent , Death, Sudden, Cardiac/epidemiology , Death, Sudden, Cardiac/etiology , Defibrillators, Implantable , Female , Humans , Male , Registries , Risk Factors , Stroke Volume , Tachycardia, Ventricular , Ventricular Function, Left
2.
Echocardiography ; 31(1): E10-2, 2014.
Article in English | MEDLINE | ID: mdl-24102705

ABSTRACT

We describe the use of vector flow mapping (VFM), a novel echocardiographic technique allowing intracardiac flow visualization, to quantify flow intensity inside a left ventricular aneurysm in a 68-year-old man. VFM successfully identified areas of stagnant flow corresponding to the wall region where a thrombus had been formed.


Subject(s)
Echocardiography/methods , Heart Aneurysm/complications , Heart Aneurysm/diagnostic imaging , Thrombosis/diagnostic imaging , Thrombosis/etiology , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/etiology , Aged , Feasibility Studies , Humans , Male , Rheology/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...